Your session is about to expire
← Back to Search
Behavioral Intervention
PRYSHM Program for LGBTQIA+ Youth Well-Being (PRYSHM Trial)
N/A
Waitlist Available
Research Sponsored by University of Nebraska Lincoln
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 9, and week 21
Awards & highlights
No Placebo-Only Group
Summary
This trial tests an online program called PRYSHM to help prevent dating violence and alcohol use among LGBTQ+ youth aged 15 to 18. The program addresses stress from discrimination and builds a sense of community to reduce risky behaviors. It is especially aimed at youth in rural areas who may not have access to in-person support.
Who is the study for?
This trial is for LGBTQIA2S+ youth aged 15-18 in the U.S. who are currently or recently were in a romantic relationship, can attend weekly online sessions, and have internet access. It's not for those outside this age range, full-time college students, heterosexual and cisgender individuals, or those at high risk of suicide.
What is being tested?
The PRYSHM program is being tested to prevent dating abuse and alcohol misuse among sexual and gender minority youths. Participants will join an online curriculum with weekly sessions to assess its effectiveness and acceptance.
What are the potential side effects?
Since PRYSHM is an educational intervention rather than a medical treatment, it may not have typical 'side effects,' but participants might experience emotional discomfort discussing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 9, and week 21
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 9, and week 21
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline in Alcohol Use at Week 9 and Week 21
Change from Baseline in Drinking Intentions at Week 9 and Week 21
Change from Baseline in Intimate partner violence perpetration at Week 9 and Week 21
+4 moreSecondary study objectives
Change from Baseline in Depressive Symptoms at Week 9 and Week 21
Change from Baseline in Drug Use at Week 9 and Week 21
Change from Baseline in Experience of Negative Consequences as a Result of Alcohol Use at Week 9 and Week 21
+1 moreOther study objectives
Baseline measure in Family Rejection
Change from Baseline in Accurate Perceptions of Alcohol Use at Week 9 and Week 21
Change from Baseline in Accurate Perceptions of Dating Violence at Week 9 and Week 21
+13 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment ConditionExperimental Treatment1 Intervention
The PRYSHM program is theoretically grounded, follows best practices for effective health behavior prevention, and includes nine, one hour sessions co-facilitated by 2 LGBTQ+ adults.
Group II: ControlActive Control1 Intervention
Check-ins/provision of resources
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Promoting Resilient Youth with Strong Hearts and Minds (PRYSHM)
2022
N/A
~310
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for dating abuse, such as the Online Synchronous DV and AU Prevention Curriculum, typically involve behavioral interventions that focus on cognitive-behavioral therapy (CBT) and motivational interviewing (MI). These treatments work by helping individuals recognize and change harmful thought patterns and behaviors, improving their coping strategies, and enhancing their motivation to change.
For dating abuse patients, these mechanisms are crucial as they address both the psychological and behavioral aspects of abuse, promoting healthier relationship dynamics and reducing the risk of substance use that can exacerbate abusive behaviors.
Attrition from a male batterer treatment program: client-treatment congruence and lifestyle instability.Developing an Integrated Violence Prevention for Men and Women in Treatment for Substance Use Disorders.Motivational interviewing and intimate partner violence: a randomized trial.
Attrition from a male batterer treatment program: client-treatment congruence and lifestyle instability.Developing an Integrated Violence Prevention for Men and Women in Treatment for Substance Use Disorders.Motivational interviewing and intimate partner violence: a randomized trial.
Find a Location
Who is running the clinical trial?
University of Nebraska LincolnLead Sponsor
36 Previous Clinical Trials
12,346 Total Patients Enrolled
University of HoustonOTHER
150 Previous Clinical Trials
47,615 Total Patients Enrolled
University of Colorado, Colorado SpringsOTHER
18 Previous Clinical Trials
5,075 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not proficient in English, either in writing or speaking.I am either younger than 15 or older than 18 years old.I am between 15 and 18 years old.I cannot attend weekly one-hour sessions.I can attend 9 weekly online sessions, each lasting an hour.I identify as heterosexual and cisgender.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Treatment Condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger